CN Patent

CN101384172A — N-[2,4-双（1,1-二甲基乙基）-5-羟基苯基]-1,4-二氢-4-氧代喹啉-3-甲酰胺的固体形式

Assigned to Vertex Pharmaceuticals Inc · Expires 2009-03-11 · 17y expired

What this patent protects

本发明涉及N－[2，4－双(1，1－二甲基乙基)－5－羟基苯基]－1，4－二氢－4－氧代喹啉－3－甲酰胺(化合物1)的固体形式、其药物组合物及其使用方法。

USPTO Abstract

本发明涉及N－[2，4－双(1，1－二甲基乙基)－5－羟基苯基]－1，4－二氢－4－氧代喹啉－3－甲酰胺(化合物1)的固体形式、其药物组合物及其使用方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN101384172A
Jurisdiction: CN
Classification: —
Expires: 2009-03-11
Drug substance claim: No
Drug product claim: No
Assignee: Vertex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.